year 18, Issue 3 (May - June 2024)
Iran J Med Microbiol 2024, 18(3): 181-189 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Salehi M, Soleimany A, Shakoori Farahani A, Yavarian J, Arabzadeh M, Bolouki Azari H, et al . Clinical Characteristics and Outcomes of Influenza A (H3N2/H1N1) Infection in Hospitalized Patients: A Report From Iran 2022-2023 Cold Season Outbreak. Iran J Med Microbiol 2024; 18 (3) :181-189
URL: http://ijmm.ir/article-1-2319-en.html
URL: http://ijmm.ir/article-1-2319-en.html
Mohammadreza Salehi1 
, Arman Soleimany2 , Abbas Shakoori Farahani3 , Jila Yavarian4 , Mohammad Arabzadeh5 , Helya Bolouki Azari2 , Maryam Edalatifard6 , Abolfazl Sobati7 , Ramin Rahimnia8 , Sina Arefi2 , Mahsa Doomanlou9
, Arman Soleimany2 , Abbas Shakoori Farahani3 , Jila Yavarian4 , Mohammad Arabzadeh5 , Helya Bolouki Azari2 , Maryam Edalatifard6 , Abolfazl Sobati7 , Ramin Rahimnia8 , Sina Arefi2 , Mahsa Doomanlou9
1- Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
2- Department of Infectious Diseases, Imam Khomeini Hospital Complex, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3- Department of Medical Genetics, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran ,shakooria@sina.tums.ac.ir
4- Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
5- COVID-19 Laboratory, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
6- Thoracic Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
7- Department of Nursing and Midwifery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
8- Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
9- Genetics Laboratory, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
2- Department of Infectious Diseases, Imam Khomeini Hospital Complex, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3- Department of Medical Genetics, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran ,
4- Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
5- COVID-19 Laboratory, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
6- Thoracic Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
7- Department of Nursing and Midwifery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
8- Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
9- Genetics Laboratory, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Abstract: (840 Views)
Background and Aim: Influenza A subtypes H3N2 and H1N1 are currently circulating among humans and are the main cause of seasonal epidemics in the temperate regions. The specific clinical features of influenza H1N1 and H3N2 infections have not been well evaluated in Iranian patients.
Materials and Methods: An observational study was conducted on influenza-confirmed patients in Imam Khomeini Hospital Complex, Tehran, Iran from October 2022 to March 2023. The specimens tested positive for influenza, using RT-PCR, were transported to the National Influenza Center (NIC) Laboratory for the typing identification. Different data, including demographics, comorbidities, length of hospitalization, outcomes, paraclinical features, and recent influenza vaccination, were collected.
Results: A number of 165 hospitalized patients with influenza infection were included: 148 (89.70%) patients with H3N2 and 17 (10.30%) with H1N1 infections. Among the patients 55.20% were male. The median age was 49 years. The patients were symptomatic for an average of 8 days. The most common symptoms were dyspnea (60.6%), fever (58.8%), and productive cough (37.6%). The median oxygen saturation was significantly lower in the H3N2 group (91%–81.0, 96.0) than in the H1N1 group (95%–90.0, 97.5) (P=0.029). The ground glass opacity (GGO) was the most common (69.1%) pulmonary radiological pattern. Only one patient had received the influenza vaccine in the recent year.. The mortality rate (19 patients: 11.55%) was associated with the cancer and liver diseases.
Conclusion: Influenza A (H3N2 and H1N1) can be considered the outbreak cause in Iran in 2022–2023. The vaccination rate was very low and the mortality rate was high. Influenza vaccination is recommended to prevent death, especially in the patients with cancer.
Type of Study: Original Research Article |
Subject:
Medical Virology
Received: 2024/03/15 | Accepted: 2024/07/9 | ePublished: 2024/08/18
Received: 2024/03/15 | Accepted: 2024/07/9 | ePublished: 2024/08/18
References
1. Poehling KA, Edwards KM, Griffin MR, Szilagyi PG, Staat MA, Iwane MK, et al. The burden of influenza in young children, 2004-2009. Pediatrics. 2013;131(2):207-16. [DOI:10.1542/peds.2012-1255] [PMID] [PMCID]
2. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beings. Lancet Infect Dis. 2007;7(4):257-65. [DOI:10.1016/S1473-3099(07)70029-4] [PMID]
3. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, et al. The global circulation of seasonal influenza A (H3N2) viruses. Science. 2008;320(5874):340-6. [DOI:10.1126/science.1154137] [PMID]
4. World Health Organization (WHO). Guidelines for the clinical management of severe illness from influenza virus infections: World Health Organization; 2022. Retrieved from: [https://www.who.int/publications/i/item/9789240040816]
5. Fragaszy EB, Warren‐Gash C, White PJ, Zambon M, Edmunds WJ, Nguyen‐Van‐Tam JS, et al. Effects of seasonal and pandemic influenza on health‐related quality of life, work and school absence in England: results from the Flu Watch cohort study. Influenza Other Respir Viruses. 2018;12(1):171-82. [DOI:10.1111/irv.12506] [PMID] [PMCID]
6. Killingley B, Nguyen‐Van‐Tam J. Routes of influenza transmission. Influenza Other Respir Viruses. 2013;7:42-51. [DOI:10.1111/irv.12080] [PMID] [PMCID]
7. Lai PL, Panatto D, Ansaldi F, Canepa P, Amicizia D, Patria AG, et al. Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A/California/07/09) pandemic. Hum Vaccin. 2011;7(Suppl01):217-25. [DOI:10.4161/hv.7.0.14607] [PMID]
8. Davidson MW, Haim DA, Radin JM. Using Networks to Combine “Big Data” and Traditional Surveillance to Improve Influenza Predictions. Sci Rep. 2015;5(1):1-5. [DOI:10.1038/srep08154] [PMID] [PMCID]
9. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol. 2005;79(5):2814-22. [DOI:10.1128/JVI.79.5.2814-2822.2005] [PMID] [PMCID]
10. Hosseini S, Karami M, Farhadian M, Mohammadi Y. Seasonal activity of influenza in Iran: application of influenza-like illness data from sentinel sites of healthcare centers during 2010 to 2015. J Epidemiol Glob Health. 2018;8(1-2):29-33. [DOI:10.2991/j.jegh.2018.08.100] [PMID] [PMCID]
11. Newton DW, Treanor JJ, Menegus MA. Clinical and laboratory diagnosis of influenza virus infections. Am J Manag Care. 2000;6(5 suppl):S265-75.
12. Martínez A, Soldevila N, Romero-Tamarit A, Torner N, Godoy P, Rius C, et al. Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype. PLoS One. 2019;14(1):e0210353. [DOI:10.1371/journal.pone.0210353] [PMID] [PMCID]
13. Gouya M, Soroush M, Mokhtari-Azad AT, Haghdoost A, Hemati P, Moghadami M, et al. Influenza A (H1N1) Pandemic in Iran: Report of First Confirmed Cases from June to November 2009. Arch Iran Med. 2010;13(2):91-8.
14. Soudani S, Mafi A, Al Mayahi Z, Al Balushi S, Dbaibo G, Al Awaidy S, et al. A Systematic Review of Influenza Epidemiology and Surveillance in the Eastern Mediterranean and North African Region. Infect Dis Ther. 2022;11(1):15-52. [DOI:10.1007/s40121-021-00534-3] [PMID] [PMCID]
15. Mozhgani S-H, Ghobadi MZ, Moeini S, Pakzad R, Kananizadeh P, Behzadian F. Prevalence of human influenza virus in Iran: Evidence from a systematic review and meta-analysis. Microb Pathog. 2018;115:168-74. [DOI:10.1016/j.micpath.2017.12.064] [PMID]
16. Yavarian J, Shafiei-Jandaghi NZ, Rahimi-Foroushani A, Shadab A, Ghamarchehreh M, Mokhtari-Azad T. Human metapneumovirus and influenza viruses in children with severe acute respiratory infections in Iran. Iran J Pediatr. 2018;28(1):e60948. [DOI:10.5812/ijp.60948]
17. Dhanasekaran V, Sullivan S, Edwards KM, Xie R, Khvorov A, Valkenburg SA, et al. Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination. Nat Commun. 2022;13(1):1721. [DOI:10.1038/s41467-022-29402-5] [PMID] [PMCID]
18. MohammadEbrahimi S, Kiani B, Rahmatinejad Z, Baral S, Hashtarkhani S, Dehghan-Tezerjani M, et al. Geospatial epidemiology of hospitalized patients with a positive influenza assay: A nationwide study in Iran, 2016-2018. PloS One. 2022;17(12):e0278900. [DOI:10.1371/journal.pone.0278900] [PMID] [PMCID]
19. Soepandi PZ, Burhan E, Mangunnegoro H, Nawas A, Aditama TY, Partakusuma L, et al. Clinical course of avian influenza A (H5N1) in patients at the Persahabatan Hospital, Jakarta, Indonesia, 2005-2008. Chest. 2010;138(3):665-73. [DOI:10.1378/chest.09-2644] [PMID] [PMCID]
20. Hong K-W, Cheong HJ, Choi WS, Lee J, Wie S-H, Baek JH, et al. Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillance. J Infect Chemother. 2014;20(1):9-14. [DOI:10.1016/j.jiac.2013.07.001] [PMID]
21. Plessa E, Diakakis P, Gardelis J, Thirios A, Koletsi P, Falagas ME. Clinical features, risk factors, and complications among pediatric patients with pandemic influenza A (H1N1). Clin Pediatr. 2010;49(8):777-81. [DOI:10.1177/0009922810368558] [PMID]
22. Kaji M, Watanabe A, Aizawa H. Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients. Respirology. 2003;8(2):231-3. [DOI:10.1046/j.1440-1843.2003.00457.x] [PMID]
23. Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP. Does this patient have influenza?. JAMA. 2005;293(8):987-97. [DOI:10.1001/jama.293.8.987] [PMID]
24. Koliou M, Soteriades E, Toumasi M, Demosthenous A, Hadjidemetriou A. Epidemiological and clinical characteristics of influenza A (H1N1) v infection in children: the first 45 cases in Cyprus, June-August 2009. Eurosurveillance. 2009;14(33):19312. [DOI:10.2807/ese.14.33.19312-en] [PMID]
25. Larcombe PJ, Moloney SE, Schmidt PA. Pandemic (H1N1) 2009: a clinical spectrum in the general paediatric population. Arch Dis Child. 2011;96(1):96-8. [DOI:10.1136/adc.2009.176859] [PMID]
26. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Supplement_2):S27-S72. [DOI:10.1086/511159] [PMID] [PMCID]
27. Abdelsalam M, Diab HS, Ragab Y. Radiological findings in patients with H1N1 influenza pneumonia. Egypt J Chest Dis Tuberc. 2016;65(1):135-42. [DOI:10.1016/j.ejcdt.2015.07.001]
28. Erçen Diken Ö, Arslan S, AKDoğAN Ö, Yapar D, Ünal Ö, Demir E, et al. Clinical, radiological and prognostic features of influenza cases in the influenza epidemic during years 2016-2017. Tuberk Toraks. 2018;66(2):144-9. [DOI:10.1016/j.ejcdt.2015.07.001] [PMCID]
29. Li L, Wong JY, Wu P, Bond HS, Lau EH, Sullivan SG, et al. Heterogeneity in estimates of the impact of influenza on population mortality: a systematic review. Am J Epidemiol. 2018;187(2):378-88. [DOI:10.1093/aje/kwx270] [PMID] [PMCID]
30. Metersky ML, Masterton RG, Lode H, File Jr TM, Babinchak T. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis. 2012;16(5):e321-e31. [DOI:10.1016/j.ijid.2012.01.003] [PMID]
31. Lee KH, Gordon A, Foxman B. The role of respiratory viruses in the etiology of bacterial pneumonia: an ecological perspective. Evol Med Public Health. 2016;2016(1):95-109. [DOI:10.1093/emph/eow007] [PMID] [PMCID]
32. Sonoguchi T, Naito H, Hara M, Takeuchi Y, Fukumi H. Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J Infect Dis. 1985;151(1):81-8. [DOI:10.1093/infdis/151.1.81] [PMID]
33. Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016;16(8):942-51. [DOI:10.1016/S1473-3099(16)00129-8] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright Policy
Iranian Journal of Medical Microbiology by Farname is licensed under CC BY-NC 4.0
